Recombinant Neisseria meningitidis serogroup B Putative Zinc Metalloprotease NMB0183, or NMB0183, is a protein expressed by the bacterium Neisseria meningitidis serogroup B . N. meningitidis is a bacterium that can cause serious infections, including meningitis and septicemia . NMB0183 is annotated as a putative zinc metalloprotease, suggesting it may utilize a zinc ion to perform its enzymatic function as a protease . Metalloproteases are enzymes that catalyze the hydrolysis of peptide bonds in proteins, using a metal ion, such as zinc, in their active site .
The precise function of NMB0183 in N. meningitidis is not yet fully understood, but it is likely involved in bacterial physiology or pathogenesis due to its classification as a putative zinc metalloprotease . Some potential functions and significance include:
Nutritional Immunity and Metal Acquisition: N. meningitidis expresses proteins like CbpA (also referred to as TdfH), which can bind to proteins like calprotectin to acquire zinc, an essential nutrient, from the host environment . NMB0183 may play a role in processing proteins involved in metal acquisition or in the bacteria's response to nutritional immunity .
Virulence and Pathogenesis: Metalloproteases are known virulence factors in various bacteria . They can degrade host tissues, inactivate immune components, or interfere with host cell signaling pathways . NMB0183 could contribute to the ability of N. meningitidis to colonize, invade, and cause disease .
Vaccine Antigen Discovery: Proteins expressed by N. meningitidis during bloodstream infection are of interest as potential vaccine candidates . Upregulation of certain genes, including those encoding surface-exposed proteins, suggests their importance for bacterial survival and makes them attractive targets for vaccine development .
Zinc metalloproteases, like NMB0183, are characterized by the presence of a zinc ion in their active site, which is essential for their catalytic activity . These enzymes typically have a conserved motif, such as HEXXH, that coordinates the zinc ion . The zinc ion assists in the hydrolysis of peptide bonds by polarizing the carbonyl group of the substrate and stabilizing the transition state .
KEGG: nme:NMB0183
STRING: 122586.NMB0183
Methodological approach:
Expression system selection:
Expression optimization:
Test multiple induction conditions (IPTG concentration, temperature, duration)
Validate expression using SDS-PAGE and Western blot
Monitor for inclusion body formation and adjust conditions as needed
Purification protocol:
Implement a multi-step purification strategy:
a. Affinity chromatography (Ni-NTA for His-tagged protein)
b. Ion-exchange chromatography for removing impurities
c. Size-exclusion chromatography for final polishing
Assess purity using SDS-PAGE and mass spectrometry
Validate protein folding using circular dichroism
Storage optimization:
Methodological approach:
Genetic manipulation studies:
Generate NMB0183 knockout mutants using transposon mutagenesis or CRISPR-Cas9
Create complemented strains to confirm phenotypes
Develop point mutations to assess specific functional domains
Virulence assessment:
Compare wild-type and mutant strains in cellular adhesion and invasion assays
Assess biofilm formation capabilities using crystal violet staining
Evaluate serum resistance through complement-mediated killing assays
Host-pathogen interaction models:
Use human nasopharyngeal epithelial cell lines for adhesion studies
Implement transwell systems to study bacterial translocation
Employ primary human cell cultures to evaluate immune responses
Methodological approach:
Enzymatic activity characterization:
Design fluorogenic peptide substrates based on predicted cleavage sites
Establish a zinc-dependent activity assay with various metal chelators as controls
Determine enzyme kinetics (Km, Vmax, kcat) under varying pH and temperature conditions
Perform inhibitor studies with known metalloprotease inhibitors
Substrate identification:
Conduct proteomic analyses using techniques such as:
a. TAILS (Terminal Amine Isotopic Labeling of Substrates)
b. PICS (Proteomic Identification of Cleavage Sites)
c. Degradomics approaches with N-terminomics
Validate identified substrates using in vitro cleavage assays with purified components
Generate non-cleavable substrate mutants for functional validation
Structure-function analysis:
Implement site-directed mutagenesis targeting conserved metalloprotease motifs
Perform alanine-scanning mutagenesis of the active site
Develop truncated variants to identify minimal catalytic domains
Use molecular dynamics simulations to predict substrate binding
Experimental design considerations:
Include appropriate positive controls (known metalloproteases) in parallel experiments
Implement rigorous statistical analysis following principles detailed in "Experimental Design and Data Analysis for Biologists"
Consider factorial designs to identify interaction effects between experimental variables
A robust experimental design would follow the principles outlined in Quinn and Keough's approach, utilizing appropriate statistical tests based on the nature of your data and incorporating controls for population structure when analyzing strain variations .
Methodological approach:
Antigenicity assessment:
Analyze recombinant NMB0183 using:
a. ELISA with sera from convalescent patients
b. Western blotting against diverse patient samples
c. Surface plasmon resonance for antibody affinity measurement
Compare immunoreactivity across geographically diverse clinical isolates
Assess cross-reactivity with proteins from related Neisseria species
Epitope mapping strategies:
Implement peptide arrays covering the full NMB0183 sequence
Use hydrogen-deuterium exchange mass spectrometry for conformational epitope identification
Employ phage display libraries for high-resolution epitope mapping
Validate identified epitopes using site-directed mutagenesis
Immunogenicity studies:
Design recombinant constructs with optimal epitope presentation
Evaluate adjuvant formulations for enhanced immune response
Measure both humoral and cellular immune responses in animal models
Assess memory B-cell responses using ELISpot assays
Translation to vaccine development:
Recent approaches to MenB vaccine development have shifted from polysaccharide-based vaccines to outer membrane proteins due to the poor immunogenicity of the polysaccharide approach . When evaluating NMB0183 as a vaccine candidate, researchers should consider using genetic Meningococcal Antigen Typing System (gMATS) as a correlate for predicting strain coverage .
Methodological approach:
Comparative genomic analysis:
Conduct protein homology searches against characterized LOS biosynthesis enzymes
Perform synteny analysis to identify genomic context near NMB0183
Use structural prediction algorithms to identify potential glycosyltransferase or modification domains
Compare sequence conservation across diverse meningococcal lineages
Molecular interaction studies:
Implement bacterial two-hybrid systems to detect protein-protein interactions
Use pull-down assays with tagged NMB0183 to identify interaction partners
Perform co-immunoprecipitation followed by mass spectrometry
Validate interactions with biolayer interferometry or isothermal titration calorimetry
LOS structural analysis:
Extract and analyze LOS from wild-type and NMB0183 mutant strains using:
a. Mass spectrometry (MALDI-TOF, ESI-MS)
b. NMR spectroscopy
c. Compositional analysis of monosaccharides
Assess changes in LOS phosphoethanolamine content, as phosphorylation of LOS components is important in N. meningitidis virulence
Functional assays:
Compare serum resistance between wild-type and mutant strains
Evaluate complement activation using CH50 and AP50 assays
Assess binding to various lectins to determine glycosylation patterns
Measure TLR4 activation using reporter cell lines
When designing these experiments, it's important to note that LOS structure is critical for N. meningitidis virulence, as demonstrated in previous studies on inner core biosynthesis . The absence of certain glycosyltransferases can significantly impact bacterial survival and pathogenicity.
Methodological approach:
Identification of binding partners:
Perform protein microarray screening against human serum proteins
Use surface plasmon resonance to detect direct binding to candidate host proteins
Implement affinity purification-mass spectrometry using tagged NMB0183
Screen against human tissue extracts using far-western blotting
Functional validation:
Develop cell-based assays to assess:
a. Attachment to human cell lines
b. Internalization efficiency
c. Cytotoxic effects
d. Intracellular trafficking
Compare wild-type bacteria with NMB0183 knockouts in these assays
Use siRNA knockdown of identified host receptors to confirm specificity
Host response characterization:
Measure cytokine/chemokine profiles after exposure to purified NMB0183
Assess NF-κB activation and inflammasome induction
Evaluate neutrophil recruitment and activation
Measure impact on complement activation pathways
In vitro model systems:
Develop 3D cell culture models of blood-brain barrier
Use human nasopharyngeal tissue explants
Implement organ-on-chip platforms for dynamic interaction studies
Employ human immune cell co-culture systems
These approaches should consider that N. meningitidis virulence factors often interact with multiple host proteins. Recent studies have shown that factors like factor H binding protein (FHbp) are important targets in vaccine development , suggesting methodologies used to study such interactions could be adapted for NMB0183 research.
Methodological approach:
Integrated experimental design:
Collect paired samples for transcriptomics, proteomics, and metabolomics analysis
Compare wild-type, NMB0183 knockout, and complemented strains
Include relevant environmental conditions (iron limitation, serum exposure, etc.)
Design time-course experiments to capture dynamic responses
Multi-omics data generation:
Transcriptomics: RNA-seq to identify differentially expressed genes in response to NMB0183 mutation
Proteomics: Quantitative proteomics (TMT/iTRAQ) to measure protein-level changes
Secretomics: Analysis of secreted/surface proteins in wild-type vs. mutant strains
Metabolomics: Targeted and untargeted approaches to identify metabolic perturbations
Data integration strategies:
Implement network analysis using tools like:
a. Weighted gene co-expression network analysis (WGCNA)
b. Bayesian network inference
c. Multi-omics factor analysis (MOFA)
Develop causal models linking genetic perturbation to phenotypic outcomes
Use machine learning approaches to identify key signatures associated with NMB0183 function
Validation experiments:
Confirm key pathways using targeted gene knockouts
Implement CRISPR interference for temporal control of gene expression
Use chemical inhibitors of identified pathways to validate predictions
Develop reporter strains to monitor pathway activation in real-time
When designing multi-omics studies, researchers should ensure proper statistical design, including consideration of sample size, biological replicates, and appropriate controls as outlined in experimental design principles . Analysis should account for potential strain-to-strain variation, as genetic diversity studies have shown significant variation among meningococcal isolates .
Methodological approach:
Expression system selection:
Prokaryotic systems:
Eukaryotic alternatives:
Pichia pastoris for proper folding of complex proteins
Insect cell expression for mammalian-like post-translational modifications
Mammalian expression for authentic human-like glycosylation
Optimization strategies:
Implement factorial design experiments testing:
a. Induction temperature (16°C, 25°C, 37°C)
b. Inducer concentration (0.1-1.0 mM IPTG)
c. Induction duration (4h, 8h, overnight)
d. Media composition (LB, TB, auto-induction)
Assess protein solubility and yield using SDS-PAGE and Western blotting
Screen buffer conditions using differential scanning fluorimetry
Construct design considerations:
Design multiple constructs with:
a. Various affinity tags (His, GST, MBP, SUMO)
b. Different tag positions (N-terminal vs. C-terminal)
c. Inclusion of TEV protease cleavage sites
d. Domain truncations based on structural predictions
Protein quality assessment:
Validate protein folding using circular dichroism
Assess oligomeric state using size-exclusion chromatography
Confirm zinc incorporation using inductively coupled plasma mass spectrometry
Evaluate homogeneity via dynamic light scattering
For structural studies, researchers should consider following the buffer optimization approach using Tris-based buffer with 50% glycerol as indicated in the product specifications , but must be prepared to screen numerous conditions for crystallization or NMR studies.
Methodological approach:
Experimental design considerations:
Implement nested or factorial designs to account for strain and condition variations
Calculate appropriate sample sizes through power analysis
Include appropriate technical and biological replicates
Control for batch effects through randomization and blocking
Statistical analysis framework:
For comparing NMB0183 variants across strains:
a. Analysis of variance (ANOVA) for multiple group comparisons
b. Mixed linear models for nested/hierarchical data
c. Non-parametric alternatives when normality assumptions are violated
For genomic associations:
a. Implement linear mixed models to account for population structure
b. Apply multiple testing correction appropriate to hypothesis
c. Consider statistical thresholds based on number of independent tests
Advanced statistical approaches:
For phenotype-genotype associations:
a. Use SNP-based heritability analyses with genomic relatedness matrices
b. Implement simulation-based power calculations
c. Consider Bayesian approaches for complex trait analysis
For multivariate outcomes:
a. Principal component analysis for dimensionality reduction
b. MANOVA for multiple outcome variables
c. Structural equation modeling for causal pathway analysis
Data visualization and reporting:
Generate appropriate visualizations (Manhattan plots, Q-Q plots)
Report effect sizes with confidence intervals, not just p-values
Include detailed methods section with statistical software and parameters
Make raw data available for reproducibility
When designing experiments with multiple meningococcal strains, researchers should note the importance of accounting for population structure, as demonstrated in genome-wide association studies of N. meningitidis . Statistical approaches should be tailored to the specific experimental questions and data characteristics.
Methodological approach:
CRISPR system design:
Select appropriate Cas9 variant (SpCas9, SaCas9) for N. meningitidis
Design custom promoters suitable for meningococcal expression
Develop efficient delivery systems (plasmid transformation, conjugation)
Implement inducible Cas9 expression to minimize toxicity
sgRNA design strategy:
Target multiple sites within NMB0183 gene using prediction algorithms
Evaluate off-target potential against meningococcal genome
Design sgRNAs with optimal GC content and minimal secondary structure
Include PAM-proximal seed region specificity checks
Repair template design:
For gene knockout:
a. Design homology arms (500-1000bp) flanking target region
b. Include selectable markers (antibiotic resistance)
c. Add unique restriction sites for screening
For precise editing:
a. Introduce silent mutations to prevent re-cutting
b. Design mutations that preserve protein folding
c. Consider codon optimization for expression
Screening and validation:
Implement PCR-based screening strategies for edited clones
Confirm edits by Sanger sequencing
Validate phenotypic consequences using functional assays
Perform whole genome sequencing to check for off-target effects
When implementing CRISPR-Cas9 in N. meningitidis, researchers should consider strain-specific differences in transformation efficiency and DNA uptake sequences. Previous genetic manipulation studies in N. meningitidis have used transposon mutagenesis , but CRISPR-Cas9 offers potential advantages for precise genetic manipulation.
Methodological approach:
Challenge: Limited understanding of natural variation
Challenge: Unknown contribution to protective immunity
Solution:
Develop animal models appropriate for testing NMB0183-based immunity
Implement serum bactericidal assays using human complement
Measure antibody responses in convalescent sera from patients
Compare protection against diverse meningococcal isolates
Challenge: Integration with existing vaccine components
Challenge: Translating animal studies to human prediction
Solution:
Develop in vitro correlates of protection using human immune cells
Use human tissue models for evaluating antibody functionality
Implement systems vaccinology approaches to identify response biomarkers
Design challenge studies in appropriate animal models
When evaluating NMB0183 for vaccine potential, researchers should consider that current MenB vaccines target outer membrane proteins that elicit broad protective responses . The development process should include strain coverage prediction methods similar to those used for existing vaccines, where predicted coverage has been estimated to be around 62.7% in some populations .
Methodological approach:
Systematic review of methodological differences:
Create a comprehensive comparison table of experimental conditions
Identify key variables that differ between studies (strain backgrounds, media, assays)
Implement meta-analysis approaches where appropriate
Develop standardized protocols for key assays
Direct experimental comparison:
Design experiments that directly test conflicting hypotheses in parallel
Use identical strains, reagents, and protocols across laboratories
Implement blinded analysis to reduce confirmation bias
Conduct inter-laboratory validation studies
Integration of multiple data types:
Combine data from different experimental approaches:
a. Genetic (gene deletion, complementation)
b. Biochemical (in vitro activity assays)
c. Structural (protein interaction studies)
d. Systems-level (transcriptomics, proteomics)
Develop models that can account for apparently conflicting observations
Identify conditions under which different functions predominate
Alternative hypothesis generation:
Consider multifunctional roles for NMB0183
Evaluate strain-specific differences as explanations
Assess impact of experimental conditions on protein function
Develop new experimental systems to reconcile divergent results
When addressing conflicting data, researchers should consider implementing robust experimental design principles as outlined in "Experimental Design and Data Analysis for Biologists" , ensuring appropriate statistical power, biological replicates, and controls for confounding variables.